Lucid Diagnostics Inc. entered into subscription agreements with accredited investors for the sale of Series B-1 Convertible Preferred Stock, raising approximately $11.6 million.
AI Assistant
LUCID DIAGNOSTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.